Land: Australia
Språk: engelsk
Kilde: APVMA (Australian Pesticides and Veterinary Medicines Authority)
OXYTETRACYCLINE AS THE DIHYDRATE
AVET HEALTH LIMITED
PARENTERAL LIQUID/SOLUTION/SUSPENSION
OXYTETRACYCLINE AS THE DIHYDRATE ANTIBIOTIC Active 300.0 mg/ml
100 mL; 250 mL; 500 mL
VM - Veterinary Medicine
ANTIBIOTIC & RELATED
Poison schedule: 4; Withholding period: MEAT (Cattle): DO NOT USE less than 35 d ays before slaughter for human consumpti on. MEAT (Sheep and Pigs): DO NOT USE l ess than 28 days before slaughter for hu man consumption. MILK: Milk collected from cows within 7 days (14 milkings) or ewes within 8 days (16 milkings) follo wing treatment MUST NOT BE USED or proce ssed for human consumption, or fed to b obby calves. Any variation by the presc ribing veterinarian to the approved dose , frequency, duration, route, disease o r target species may result in the need to extend the approved withholding peri od. EXPORT SLAUGHTER INTERVAL (ESI) Ca ttle: DO NOT USE less than 35 days befor e slaughter for export. Sheep and Pigs: DO NOT USE less than 28 days before sla ughter for export. Before using this pr oduct, confirm the current ESI from AVet Health Pty Ltd on 1300 28 38 28 or the APVMA website (www.apvma.gov.au/residue s).; Host/pest details: CATTLE: [ACTINOMYCES PYOGENES, ANTIBIOTICS - ORAL, PARENTERAL, ATROPHIC RHINITIS, BACTERIAL INFECTION, BORDETELLA BRONCHISEPTICA, CHLAMYDIA SPP., ERYSIPELAS INFECTION, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, MASTITIS, MYCOPLASMA SPP., ORGANISMS SENSITIVE TO OXYTETRACYCLINE, PASTEURELLA SPP., PNEUMONIA, PROTOZOA, RICKETTSIAE, STAPHYLOCOCCUS SPP., STREPTOCOCCI]; PIGS: [ACTINOMYCES PYOGENES, ANTIBIOTICS - ORAL, PARENTERAL, BACTERIAL INFECTION, BORDETELLA BRONCHISEPTICA, CHLAMYDIA SPP., ERYSIPELAS INFECTION, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, MYCOPLASMA SPP., ORGANISMS SENSITIVE TO OXYTETRACYCLINE, PASTEURELLA SPP., PROTOZOA, RICKETTSIAE, STAPHYLOCOCCUS SPP., STREPTOCOCCI]; SHEEP: [ACTINOMYCES PYOGENES, ANTIBIOTICS - ORAL, PARENTERAL, BACTERIAL INFECTION, BACTERIAL KERATO CONJUNCTIVITIS, BORDETELLA BRONCHISEPTICA, CHLAMYDIA SPP., ENZOOTIC ABORTION, ERYSIPELAS INFECTION, FOOTROT - DICHELOBACTER NODOSUS, INFECTIONS OF THE RESPIRATORY TRACT, INFECTIONS OF THE URINARY TRACTS, MYCOPLASMA SPP., ORGANISMS SENSITIVE TO OXYTETRACYCLINE, PASTEURELLA SPP., PROTOZOA, RICKETTSIAE, STAPHYLOCOCCUS SPP., STREPTOCOCCI]
Registered
2023-07-01
Elevet+ Oxytetracycline LA 300 mg/mL Injectable 92633/136080 Product Name: APVMA Approval No: Label Name: Elevet+ Oxytetracycline LA 300 mg/mL Injectable Solution Signal Headings: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY Constituent Statements: 300 mg/mL OXYTETRACYCLINE (as the DIHYDRATE) Claims: Broad spectrum antibiotic injection for use in cattle, sheep and pigs. Elevet+ Oxytetracycline LA 300 is a broad-spectrum antibiotic for use in the treatment of conditions caused by, or associated with, organisms sensitive to oxytetracycline in cattle, sheep and pigs. A wide range of gram-positive and gram-negative bacteria, including Bordetella bronchiseptica, Actinomyces pyogenes, Erysipelothrix rhusiopathiae, Pasteurella spp., Staphylococcus spp. and Streptococcus spp. are sensitive to oxytetracycline. Certain Mycoplasma, Rickettsiae, Protozoa and Chlamydia are also sensitive to oxytetracycline. Elevet+ Oxytetracycline LA 300 may be used in the treatment and control of wide range of common systemic, respiratory, urinary and local infections caused by oxytetracycline organisms. Specific indications for this product would therefore include: Pasteurellosis, pneumonia, atrophic rhinitis, erysipelas, joint-ill/navel ill, summer mastitis in cows, ovine keratoconjuctivitis (pink-eye), foot rot and enzootic abortion in sheep. Resistance may develop to any chemical. Net Contents: 100 mL, 250 mL, 500 mL Directions for Use: Restraints: Contraindications: RLP APPROVED Precautions: Side Effects: Although this product is well-tolerated, occasionally a slight local reaction of a transient nature may be observed. The use of tetracyclines during the period of tooth and bone development, including late pregnancy, may lead to discolouration. Dosage and Administration: Use contents within 28 days of first broaching of the vial. Discard the unused portion. This product does not contain any antimicrobial preservative. Swab the septum before removing each dose. Use a sterile needle and syringe. If s Les hele dokumentet